Fuzheng Zhang
Wuxi, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
ESO-Shanghai 20: phase III clinical trial of anti-PD-1 therapy with local intervention for oligometastatic ESCC.
Journal: Future oncology (London, England)
Published: July 30, 2025
Efficacy and safety of concurrent radiotherapy and chemotherapy for locally advanced esophageal squamous cell carcinoma: a randomized controlled trial.
Journal: Journal of gastrointestinal oncology
Published: April 19, 2022
Predictive and Prognostic Value of an MicroRNA Signature for Gastric Carcinoma Undergoing Adjuvant Chemotherapy.
Journal: DNA and cell biology
Published: November 12, 2021
Sublethal irradiation promotes the metastatic potential of hepatocellular carcinoma cells.
Journal: Cancer science
Published: July 31, 2020
High expression of heme oxygenase-1 in tumor-associated macrophages characterizes a poor-prognosis subtype in nasopharyngeal carcinoma.
Journal: Aging
Published: June 02, 2020
Raltitrexed versus 5-fluorouracil with cisplatin and concurrent radiotherapy for locally advanced nasopharyngeal carcinoma: An open labeled, randomized, controlled, and multicenter clinical trial.
Journal: Cancer medicine
Published: March 28, 2020
Erlotinib enhanced chemoradiotherapy sensitivity via inhibiting DNA damage repair in nasopharyngeal carcinoma CNE2 cells.
Journal: Annals of palliative medicine
Published: November 07, 2019
Methylated PTGER4 is better than CA125, CEA, Cyfra211 and NSE as a therapeutic response assessment marker in stage IV lung cancer.
Journal: Oncology letters
Published: July 21, 2019
Radiosensitivity enhancement by combined treatment of nimotuzumab and celecoxib on nasopharyngeal carcinoma cells.
Journal: Drug design, development and therapy
Published: July 25, 2018
Intensity-modulated radiotherapy plus nimotuzumab with or without concurrent chemotherapy for patients with locally advanced nasopharyngeal carcinoma.
Journal: OncoTargets and therapy
Published: December 22, 2017
microRNA-18a Promotes Cell Migration and Invasion Through Inhibiting Dicer l Expression in Hepatocellular Carcinoma In Vitro.
Journal: Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih
Published: April 13, 2017
Last Updated: 09/26/2026